Why these stocks made a splash on the ASX today?

Summary

  • The S&P/ASX200 closes Thursday session a tad bit lower, dropped 0.37%.
  • eCargo posts gains on partnership with NZ's Fonterra unit
  • Seven West Media shares rises on strong FY21 forecast

The S&P/ASX200 closed lower Thursday, dropping 27.20 points or 0.37% to 7359 after setting a new 52-week high. Over the last five days, the index has gained 0.77% and is currently 0.64% off of its 52-week high.

Few notable stocks that ended in green are Nuix Limited (ASX:NXL, 6.15%), Netwealth Group Limited (ASX:NWL, 5.20%), Computershare Limited (ASX:CPU, 4.81%) followed by Austal Limited (ASX:ASB, 4.50% and Bank of Queensland Limited (ASX:BOQ, 3.34%).

Sectors ended mixed. 6 of 11 sectors were lower along with the S&P/ASX 200 Index. Information Technology was the best performing sector, gaining 1.26% and 3.83% for the past five days.

Now let us look at some of the stocks that were in news today:

Also read: ASX snaps 4-day gaining streak; telecom, energy stocks bleed

Nuix (ASX:NXL) climbs over 7% after volatile recent sessions

Shares of software company Nuix Limited (ASX:NXL) rose as much as 7.5% to AU$2.795 per share on Thursday.

The Macquarie-backed firm has lost more than half its value since listing in December, and around ~76% from its peak in late January.

NXL's CEO and CFO stepped down on Tuesday amid growing pressure for failing to meet targets set in its prospectus and downgrading revenue forecasts twice since.

The stock rose after the announcement on Tuesday but fell 5.8% in the previous session. It closed at AU$2.760 per share, up 6.153%.

Image Source: © Zimmytws | Megapixl.com

Vectus Biosystems (ASX:VBS) climbs on nod for lead drug's Phase I trial in Australia

Shares of Vectus Biosystems Limited (ASX:VBS) spurted up 24.752% to AU$1.260 per share on Thursday.

The biotech firm stated it has received approval for the Phase I human trial of its drug, dubbed VB0004, in healthy volunteers in Australia to study its safety and tolerability.

VB0004 is Company’s lead compound, which aims to treat the hardening of functional tissue and high blood pressure.

The stock ended 18.811% higher at AU$1.200 per share.

eCargo (ASX:ECG) rises on partnership with NZ's Fonterra unit

Shares of eCargo Holdings Ltd (ASX:ECG) closed 25% higher at AU$0.025 today.

The outsourcing services provider said it has launched its JuJiaXuan Digital Wholesale Marketplace to connect Australian brands with Chinese retailers with NZ-based dairy giant Fonterra's Australian unit.

Under the agreement, Fonterra's Australian dairies brand will be connected to 4,000 points-of-sale across mainland China.

NB Global (ASX:NBI) jumps as FY22 target distribution raised to 4.75% per annum

Shares of NB Global Corporate Income Trust (ASX:NBI) gained as much as 1.1% to AU$1.845, their biggest intraday percentage jump since 2 June 2021.

The investment manager said it will increase target distribution for financial year 2022 to 4.75% per annum.

It added, the first payment of its FY2022 target distribution will be announced at the end of July and paid in mid-August.

Image Source: © Pkripper503 | Megapixl.com

AusCann Group (ASX:AC8) sees best day in over four months on facility lease

Shares of medical marijuana producer AusCann Group Holdings Ltd (ASX:AC8) gained as much as 9.1% to touch AU$0.12 on Thursday.

The Company has entered agreement to lease its R&D facility in Western Australia to forensic tech firm Source Certain International.

The firm will receive AU$475,000 per year in rent as part of a five-year lease.

4D Medical (ASX:4DX) receives US$600K purchase order for preclinical Scanner, stock gains on ASX

4D Medical Limited (ASX:4DX) announced it has received a US$600k purchase order for a preclinical scanner from the University of Michigan.

As per the release, the order is for 4DMedical’s XV Technology™, Permetium™ preclinical scanner. It is an updated technology from 4DX’s early R&D technologies. The University of Michigan has been using the preclinical Scanner to perform safe and quick quantitative imaging of lung function and vascular changes.

4DMedical is currently focusing on the commercialisation of its software technology via integration with existing hospital X-ray infrastructure.

Meanwhile, 4DX shares closed at AU$1.295, up 1.968% on Thursday.

Do Read: Top five renewable energy stocks on ASX

Seven West Media (ASX:SWM) soars on ASX on strong FY21 forecast

Shares of Australian broadcaster Seven West Media Limited (ASX:SWM) closed 23.749% higher at AU$0.495 today.

The Company shared it expects annual underlying core earnings to range from AU$250 million to AU$255 million, against AU$129.6 million last year, helped by a strong rebound in fourth-quarter advertising revenue.

The firm stated its advertising revenue is estimated to grow more than 45% in the fourth quarter, suggesting a continuing positive momentum into the next quarter.

The Company also sees its net debt between AU$240 million and AU$250 million by the end of fiscal 2021, compared with an initial forecast of AU$270 million to AU$280 million.

Sonic Healthcare (ASX:SHL) to acquire Canberra Medical Imaging 

Sonic Healthcare Limited (ASX:SHL) shared on 17 June 2021 that it has signed a binding agreement to acquire 100% of Canberra Imaging Group (CIG).

With annual revenues of ~AU$60 million, CIG is a leading radiology practice in Canberra, with branches also located in Goulburn and Queanbeyan in New South Wales.

CIG operates one fully-funded (via Medicare), two partially-funded and two unlicensed MRI scanners and operates one of two private PET CT scanners in Canberra. It is the only private operator of an angiography and interventional day suite in the area.

Settlement of the transaction is expected in the first quarter of FY 2022, and the acquisition will be funded from cash and available debt lines.

The stock SHL closed up at AU$37.030 per share.

Must Read: How does Afterpay work?

Centuria (ASX:CNI) announces compulsory acquisition of remaining Primewest securities

Centuria Capital Limited (ASX:CNI) shared today that it has a keen interest in greater than 90% of Primewest securities. It now intends to exercise its right to acquire any outstanding Primewest securities compulsorily.

The Company stated compulsory acquisition would be on the same terms as the Centuria Offer, consisting of an offer consideration of $0.20 cash and 0.473 Centuria securities for each Primewest security.

The compulsory acquisition process, subject to the Corporations Act, is likely to take approximately 4 to 6 weeks.

Meanwhile, the stock CNI closed at AU$2.570 per share on Thursday.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK